The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice

Liver fibrosis can result from various causes and could progress to cirrhosis and cancer; however, there are no effective treatments due to that its molecular mechanism is unclear. liver fibrosis model made by ( ) infection or Carbon tetrachloride (CCl ) intraperitoneal injection is a conventional m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2020-10, Vol.11, p.570524-570524
Hauptverfasser: Song, Li-Jun, Yin, Xu-Ren, Mu, Sha-Sha, Li, Jia-Huang, Gao, Hong, Zhang, Ying, Dong, Pan-Pan, Mei, Cong-Jin, Hua, Zi-Chun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Liver fibrosis can result from various causes and could progress to cirrhosis and cancer; however, there are no effective treatments due to that its molecular mechanism is unclear. liver fibrosis model made by ( ) infection or Carbon tetrachloride (CCl ) intraperitoneal injection is a conventional model used in liver fibrosis-related studies for mechanism or pharmaceutical research purposes. But the differences in the pathological progression, immune responses and the underlying mechanism between the two liver fibrosis model have not been carefully compared and characterized, which hinders us from correctly understanding and making better use of the two models. In the present study, the pathological changes to the liver, and the cytokines, inflammatory factors, macrophages, and lymphocytes subsets involved were analyzed in the liver fibrosis model of infection or CCl intraperitoneal injection. Additionally, the pathological progression, immune responses and the underlying injury mechanism in these two models were compared and characterized. The results showed that the changing trend of interleukin-13 (IL-13), transforming growth factor beta (TGF-β), inflammatory factors, and M1, M2 macrophages, were consistent with the development trend of fibrosis regardless of whether liver fibrosis was caused by or CCl . For lymphocyte subsets, the proportions of CD3 T cells and CD4 T cells decreased gradually, while proportion of CD8 T cells peaked at 6 weeks in mice infected with and at 12 weeks in mice injected with CCl . With prolonged . infection time, Th1 (CD4 IFN-γ ) immunity converted to Th2 (CD4 IL-4 )/Th17 (CD4 IL-17 ) with weaker regulatory T cell (Treg) (CD4 CD25 FOXP3 ) immunity. However, in liver fibrosis caused by CCl , Th1 cells occupied the dominant position, while proportions of Th2, Th17, and Treg cells decreased gradually. In conclusion, liver fibrosis was a complex pathological process that was regulated by a series of cytokines and immune cells. The pathological progressions and immune responses to or CCl induced liver fibrosis were different, possibly because of their different injury mechanisms. The appropriate animal model should be selected according to the needs of different experiments and the pathogenic factors of liver fibrosis in the study.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.570524